This HubSpot Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday – Entergy (NYSE:ETR), AptarGroup (NYSE:ATR)

Sep 4, 2025
this-hubspot-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-thursday-–-entergy-(nyse:etr),-aptargroup-(nyse:atr)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Piper Sandler analyst Brent Bracelin initiated coverage on HubSpot, Inc. HUBS with an Overweight rating and announced a price target of $675. HubSpot shares closed at $472.71 on Wednesday. See how other analysts view this stock.
  • Keybanc analyst Paul Knight initiated coverage on AptarGroup, Inc. ATR with an Overweight rating and announced a price target of $220. AptarGroup shares closed at $135.22 on Wednesday. See how other analysts view this stock.
  • Jefferies analyst Paul Zimbardo initiated coverage on Entergy Corporation ETR with a Buy rating and announced a price target of $109. Entergy shares closed at $87.20 on Wednesday. See how other analysts view this stock.
  • Guggenheim analyst Bradley Canino initiated coverage on Syndax Pharmaceuticals, Inc. SNDX with a Buy rating and announced a price target of $34. Syndax Pharmaceuticals shares closed at $16.13 on Wednesday. See how other analysts view this stock.
  • Guggenheim analyst Brad Canino initiated coverage on Kura Oncology, Inc. KURA with a Neutral rating. Kura Oncology shares closed at $8.43 on Wednesday. See how other analysts view this stock.

Considering buying HUBS stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Loading…

Loading…

ATR Logo

ATRAptarGroup Inc

$136.530.97%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Edge Rankings

Momentum

24.52

Growth

78.79

Quality

57.30

Value

58.94

Price Trend

Short

Medium

Long

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Leave a comment